In Silico Studies of Crystal Structure of HCV NS5B Polymerase and Inhibitor Complex

被引:0
|
作者
Tiwari, Gargi [1 ]
Pandey, Vishnudatt [1 ]
Tiwari, Rakesh Kumar [1 ]
Ojha, Rajendra Prasad [1 ]
机构
[1] DDU Gorakhpur Univ, Dept Phys, Biophys Unit, Gorakhpur, Uttar Pradesh, India
关键词
QM/MM Molecular Dynamics Simulations; HCV; Hydrogen Bonding; AB-INITIO CALCULATIONS; MOLECULAR-DYNAMICS SIMULATIONS; ZEOLITE CATALYSTS; SYSTEMS; ALUMINOSILICATES; STABILIZATION; FIELD; ION; RNA;
D O I
10.1016/j.matpr.2018.05.029
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Quantum mechanics/molecular mechanics (QM/MM) and molecular dynamics simulations were performed to study the hydrogen bonding and polar interactions of an inhibitor namely 2-{[(5-bromothiophen-2-yl) sulfonyl] amino}- 4-chlorobenzoic acid with HCV NS5B polymerase. Using the initial poses, our aim is to identify the minimum energy positions and calculate binding affinities of inhibitor to HCV. Results suggest that the accuracy of binding affinity prediction can be significantly affected by the proper treatment of the hydrogen bonding and polar interactions. Using this protocol, we successfully identified important poses of low RMSD with respect to crystallographic structure from the initially docked poses. This work shows that the most important energetic component contributing to binding for this particular protein-ligand system is the conformational energy. In addition, formation of hydrogen bonds can produce favorable van der Waals interactions with some important residues. This systematic study can provide guidance for the choice of QM/MM MD methods and design of new inhibitors targeting HCV. (c) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:15431 / 15438
页数:8
相关论文
共 50 条
  • [1] Discovery of an irreversible HCV NS5B polymerase inhibitor
    Zeng, Qingbei
    Nair, Anilkumar G.
    Rosenblum, Stuart B.
    Huang, Hsueh-Cheng
    Lesburg, Charles A.
    Jiang, Yueheng
    Selyutin, Oleg
    Chan, Tin-Yau
    Bennett, Frank
    Chen, Kevin X.
    Venkatraman, Srikanth
    Sannigrahi, Mousumi
    Velazquez, Francisco
    Duca, Jose S.
    Gavalas, Stephen
    Huang, Yuhua
    Pu, Haiyan
    Wang, Li
    Pinto, Patrick
    Vibulbhan, Bancha
    Agrawal, Sony
    Ferrari, Eric
    Jiang, Chuan-kui
    Li, Cheng
    Hesk, David
    Gesell, Jennifer
    Sorota, Steve
    Shih, Neng-Yang
    Njoroge, F. George
    Kozlowski, Joseph A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (24) : 6585 - 6587
  • [2] DISCOVERY OF NOVEL HCV NS5B POLYMERASE INHIBITORS BY IN SILICO APPROACHES
    Karaman Mayack, Berin
    JOURNAL OF RESEARCH IN PHARMACY, 2023, 27 : 13 - 15
  • [3] HCV NS5B polymerase inhibitors
    Watkins, William J.
    Ray, Adrian S.
    Chong, Lee S.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2010, 13 (04) : 441 - 465
  • [4] HCV NS5B Polymerase Inhibitors
    Burton, James R., Jr.
    Everson, Gregory T.
    CLINICS IN LIVER DISEASE, 2009, 13 (03) : 453 - +
  • [5] Highly Diastereoselective Synthesis of a HCV NS5B Nucleoside Polymerase Inhibitor
    Zhong, Yong-Li
    Cleator, Ed
    Liu, Zhijian
    Yin, Jianguo
    Morris, William J.
    Alam, Mahbub
    Bishop, Brian
    Dumas, Aaron M.
    Edwards, John
    Goodyear, Adrian
    Mullens, Peter
    Song, Zhiguo Jake
    Shevlin, Michael
    Thaisrivongs, David A.
    Li, Hongming
    Sherer, Edward C.
    Cohen, Ryan D.
    Yin, Jingjun
    Tan, Lushi
    Yasuda, Nobuyoshi
    Limanto, John
    Davies, Antony
    Campos, Kevin R.
    JOURNAL OF ORGANIC CHEMISTRY, 2019, 84 (08): : 4780 - 4795
  • [6] The First Kilogram Synthesis of Beclabuvir, an HCV NS5B Polymerase Inhibitor
    Bien, Jeffrey
    Davulcu, Akin
    DelMonte, Albert J.
    Fraunhoffer, Kenneth J.
    Gao, Zhinong
    Hang, Chao
    Hsiao, Yi
    Hu, Wenhao
    Katipally, Kishta
    Littke, Adam
    Pedro, Aghogho
    Qiu, Yuping
    Sandoval, Maria
    Schild, Richard
    Soltani, Michelle
    Tedesco, Anthony
    Vanyo, Dale
    Vemishetti, Purushotham
    Waltermire, Robert E.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2018, 22 (10) : 1393 - 1408
  • [7] Quinolones as HCV NS5B polymerase inhibitors
    Kumar, Dange V.
    Rai, Roopa
    Brameld, Ken A.
    Somoza, John R.
    Rajagopalan, Ravi
    Janc, James W.
    Xia, Yu M.
    Ton, Tony L.
    Shaghafi, Michael B.
    Hu, Huiyong
    Lehoux, Isabelle
    To, Nhat
    Young, Wendy B.
    Green, Michael J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 82 - 87
  • [8] Characterization of forced degradation products and in silico toxicity prediction of Sofosbuvir: A novel HCV NS5B polymerase inhibitor
    Swain, Debasish
    Samanthula, Gananadhamu
    Bhagat, Shweta
    Bharatam, P. V.
    Akula, Venkatakrishna
    Sinha, Barij N.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2016, 120 : 352 - 363
  • [9] Diastereoselective synthesis of a purine phosphoramidate prodrug inhibitor of HCV NS5B polymerase
    Zhang, Hai-Ren
    Reddy, P. Ganapati
    Ross, Bruce S.
    Rachakonda, Suguna
    Sofia, Michael J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [10] Synthesis and SAR studies on rhodanine analogs as inhibitors of HCV NS5B polymerase
    Kulkarni, Shridhar
    Patel, Maulik R.
    Chudayeu, Maksim
    Kaushik, Neerja
    Talele, Tanaji T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238